Precision Quantomics Inc.
Founded in 2020 with the vision of accelerating the drug development process, Precision Quantomics Inc. specializes in the integration of quantitative proteomics into pharmacokinetic modeling to address critical gaps in drug safety and efficacy. The company’s innovative approach leverages cutting-edge technology to create tools and resources that enhance the predictability and inclusivity of drug development processes. They aim to update the current approach to toxicology testing in drug development, one collaboration at a time. For more information, visit www.precisionquantomics.com .Content by Precision Quantomics Inc.
| 2 min read
New recombinant enzyme kits set to improve personalized drug development and reduce adverse reactions in diverse patient groups.
| 3 min read
Tools provide standardized, population-informed proteomics data to benchmark emerging in vitro systems for safer, more predictive drug development.
Page 1 of 1 - 2 Total Items
